81![](https://www.pdfsearch.io/img/1b12a751799cf12ab48de68d3c00bf1d.jpg) | Add to Reading ListSource URL: www.dhhs.nh.govLanguage: English - Date: 2014-02-25 14:37:29
|
---|
82![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EVZIO safely and effectively. See full prescribing information for EVZIO. EVZIO (naloxone hydrochloride injection) A HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EVZIO safely and effectively. See full prescribing information for EVZIO. EVZIO (naloxone hydrochloride injection) A](https://www.pdfsearch.io/img/e76e123f5cea7ec78b07e6f7fb23aa1b.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2014-04-03 11:33:57
|
---|
83![Statewide Opioid Antagonist Community Access Program Intranasal Naloxone Administration Training Module Statewide Opioid Antagonist Community Access Program Intranasal Naloxone Administration Training Module](https://www.pdfsearch.io/img/5ab40a37f08b3f5a1371c396934e0861.jpg) | Add to Reading ListSource URL: www.healthvermont.govLanguage: English - Date: 2014-04-04 09:08:12
|
---|
84![Education and Training Module for Ohio EMS
Developed in the 1960s Opioid antagonist Emergent overdose treatment in the Education and Training Module for Ohio EMS
Developed in the 1960s Opioid antagonist Emergent overdose treatment in the](https://www.pdfsearch.io/img/345525f43b08ed2a73dfa32f00bd9e35.jpg) | Add to Reading ListSource URL: www.publicsafety.ohio.govLanguage: English - Date: 2014-06-18 15:48:53
|
---|
85![Statewide Opioid Antagonist Community Access Program Intranasal Administration Training Module Statewide Opioid Antagonist Community Access Program Intranasal Administration Training Module](https://www.pdfsearch.io/img/eb4c236f9801a86b29b8956c815104da.jpg) | Add to Reading ListSource URL: healthvermont.govLanguage: English - Date: 2014-04-07 13:30:35
|
---|
86![Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist) Initial REMS Approval: December[removed]NDA[removed]SUBUTEX® (buprenorphine) sublingual tablet CIII Buprenorphine (opioid partial agonist-antagonist)](https://www.pdfsearch.io/img/d2f7e54aeb80d972cfd293328f81f958.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
87![Initial REMS Approved: March[removed]Most Recent Modification: July 2013 NDA[removed]VIVITROL® (naltrexone for extended-release injectable suspension) Opioid Antagonist Initial REMS Approved: March[removed]Most Recent Modification: July 2013 NDA[removed]VIVITROL® (naltrexone for extended-release injectable suspension) Opioid Antagonist](https://www.pdfsearch.io/img/d9efaece10f0d18de76e30c64eef49f5.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
88![SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist) SUBOXONE® (buprenorphine and naloxone) sublingual film CIII Buprenorphine (opioid partial agonist‐antagonist) Naloxone (opioid antagonist)](https://www.pdfsearch.io/img/7fda0e0bbd6ab29ab00c93e15554dc2a.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
89![Development of fluorophoric and bivalent ligands at OP receptors: mobility and dynamics studies Primary Supervision: Michael Decker Secondary Supervisor: Davide Calebiro Lab webpage: http://www.pharmazie.uni-wuerzburg.de Development of fluorophoric and bivalent ligands at OP receptors: mobility and dynamics studies Primary Supervision: Michael Decker Secondary Supervisor: Davide Calebiro Lab webpage: http://www.pharmazie.uni-wuerzburg.de](https://www.pdfsearch.io/img/869bccfa9a4642c7372a4dc387486902.jpg) | Add to Reading ListSource URL: www.graduateschools.uni-wuerzburg.deLanguage: English - Date: 2014-05-13 11:14:11
|
---|
90![NCI Conference: Low Dose Opioid Blockers, Endorphins and Metenkephalins “Promising Compounds for Unmet Medical Needs” Executive Plaza North Bethesda, MD[removed]Attendees NCI Conference: Low Dose Opioid Blockers, Endorphins and Metenkephalins “Promising Compounds for Unmet Medical Needs” Executive Plaza North Bethesda, MD[removed]Attendees](https://www.pdfsearch.io/img/4e846351bd585b213bacb0eedc33b1ab.jpg) | Add to Reading ListSource URL: lowdosenaltrexone.orgLanguage: English - Date: 2007-07-07 12:12:57
|
---|